OPERON ELEVATEPLUS

Drug-Device Combination Product Consultant in Ahmedabad

Please provide the following information and we’ll put you in touch with the right person.

Ahmedabad, located in the western state of Gujarat in India, is a growing hub for the medical device industry. The city is home to several established medical device manufacturers and emerging startups. With a strong focus on innovation and research, Ahmedabad’s medical device industry is poised for significant growth in the coming years.

Combination products are a unique category of medical products that combine two or more regulated components, including drugs, devices, and biological products. As a Drug Device Combination Products Consultant in Ahmedabad, we provide comprehensive guidance on combination products under 21 CFR 3.2 (e).

Take the next step

Connect with our experts to discuss your next big medical device idea

Types of Drug-Device Combination Products

1) Pre-filled syringes 

2) Drug-eluting stents 

3) Inhalers 

4) Transdermal patches 

5 Implantable drug delivery systems 

6) Drug-device combination products for diagnostics 

7) Drug-device combination products for drug delivery systems 

8) Drug-device combination products for gene therapy

Benefits of Drug-Drug Combination Products

Despite the challenges, drug-device combination products offer many unique benefits over traditional drugs or devices alone, such as targeted therapy, improved drug delivery, and increased patient compliance. They represent an exciting and growing area of innovation in the healthcare industry, with the potential to improve patient outcomes and quality of life. 

If you are looking for expert guidance in the development and regulation of drug-device combination products in ahmedabad, Operon Strategist can help. Our team of experienced consultants offers a range of services. Contact us today to learn more.

What Sets Us Apart

Streamlined regulatory pathways to help your medical device enter global markets faster and with full compliance.

End-to-End Regulatory Documentation

Global Regulatory Expertise

Accelerated Approval Timelines

Multi-Market Compliance Support

Frequently asked questions

A drug-device combination product is a medical product that combines a drug, device, and/or biological component into a single integrated product, regulated under 21 CFR 3.2(e).

Combination products are regulated by the FDA based on their Primary Mode of Action (PMOA). The lead center (CDER, CDRH, or CBER) is assigned depending on whether the product acts primarily as a drug, device, or biologic.

Common examples include pre-filled syringes, drug-eluting stents, inhalers, transdermal patches, implantable drug delivery systems, and certain diagnostic combination products.

Manufacturers must comply with both drug and device regulatory requirements, including quality systems, labeling regulations, clinical data, risk management, and post-market surveillance.

Operon Strategist provides regulatory pathway assessment, PMOA determination, FDA submission strategy, technical documentation preparation, QMS integration, and end-to-end compliance support for drug-device combination products.

Ready to Fast-Track Your Global Regulatory Approvals

Connect with our regulatory specialist
Please provide the following information and we’ll put you in touch with the right person.